PD-L1 Expression in Squamous-cell Carcinoma and Adenocarcinoma of the Lung

BACKGROUND: With introduction of immunotherapy (IT) into the treatment of advanced non-small-cell lung cancer (NSCLC), a need for predictive biomarker became apparent. Programmed death ligand 1 (PD-L1) protein expression is most widely explored predictive marker for response to IT. We assessed PD-L1...

Descripción completa

Detalles Bibliográficos
Autores principales: Janzic, Urska, Kern, Izidor, Janzic, Andrej, Cavka, Luka, Cufer, Tanja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter Open 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5612001/
https://www.ncbi.nlm.nih.gov/pubmed/28959173
http://dx.doi.org/10.1515/raon-2017-0037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5612001/
https://www.ncbi.nlm.nih.gov/pubmed/28959173
http://dx.doi.org/10.1515/raon-2017-0037

Ejemplares similares